Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 7/2021

Open Access 01-07-2021 | Ovarian Cancer | Commentary

“From chemo to chemo”—the temporal paradox of chemotherapy

Authors: Marcin Moskalewicz, Yanna Popova, Jadwiga Wiertlewska-Bielarz

Published in: Supportive Care in Cancer | Issue 7/2021

Login to get access

Abstract

Purpose

To uncover the experience of time in women undergoing chemotherapy for ovarian cancer.

Methods

A combination of consensual qualitative research and Giorgi’s descriptive phenomenology.

Results

The key phenomenon found and pre-reflectively organizing the patients’ experience was the temporal paradox of chemotherapy—a sense of both acceleration and deceleration in between chemotherapy sessions that desynchronizes patients with the time of others.

Conclusion

The experienced paradoxes concentrating around the timings of the chemotherapy treatments are of particular relevance for supportive care. It is particularly important to acknowledge the disturbing effect of the cyclical nature of chemotherapy.
Literature
1.
Ricoeur P (1985) Time and Narrative, vol 1-3. University of Chicago Press, Chicago, IL
2.
Ellingsen S, Roxberg A, Kristoffersen K, Rosland JH, Alvsvåg H (2013) Entering a world with no future: a phenomenological study describing the embodied experience of time when living with severe incurable disease. Scand J Caring Sci 27:165–174CrossRef
3.
Dalgaard KM, Delmar C (2008) The relevance of time in palliative care nursing practice. Int J Palliat Nurs 14:472–476CrossRef
4.
Brown P, de Graaf S (2013) Considering a future which may not exist: the construction of time and expectations amidst advanced-stage cancer. Health Risk Soc 15(6-7):543–560CrossRef
5.
Lannie A, Peelo-Kilroe L (2019) Hope to hope: Experiences of older people with cancer in diverse settings. Eur J Oncol Nurs 40:71–77CrossRef
6.
Rasmussen DM, Elverdam B (2006) Cancer survivors’ experience of time - time disruption and time appropriation. J Adv Nurs 57(6):614–622CrossRef
7.
Hauge B (2016) Re-designing the everyday: the use and perception of time among cancer patients combining work and treatment. Time Soc 25(2):193–212
8.
Khatri S, Whiteley I, Gullick J, Wildbore C (2012) marking time: The temporal experience of gastrointestinal cancer. Contemp Nurse 41(2):146–159CrossRef
9.
Guenther J, Stiles A (2012) The lived Experience of Ovarian cancer: a phenomenological approach. J Am Acad Nurse Pract 24:595–603CrossRef
10.
Tsai L-Y, Tsai J-M, Tsay S-L (2020) Life experience and disease trajectories in women coexisting with ovarian cancer. Taiwan J Obstret Gynecol 59:115–119CrossRef
11.
Chou J-F, Lu Y-Y (2019) Intraperitoneal chemotherapy: the lived experiences of Taiwanese patients with ovarian cancer. Clin J Oncol Nurs 23(6):100–106CrossRef
12.
13.
Giorgi A, Giorgi B, Morley J (2017) The descriptive phenomenological psychological method. In: The SAGE Handbook of Qualitative Research in Psychology, pp 176–192CrossRef
14.
Giorgi A (2016) The descriptive phenomenological psychological method. J Phenomenol Psychol 47(1):3–12CrossRef
Metadata
Title
“From chemo to chemo”—the temporal paradox of chemotherapy
Authors
Marcin Moskalewicz
Yanna Popova
Jadwiga Wiertlewska-Bielarz
Publication date
01-07-2021
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 7/2021
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-021-06039-6

Other articles of this Issue 7/2021

Supportive Care in Cancer 7/2021 Go to the issue

Original Article

Determination of the relationship between mortality and SOFA, qSOFA, MASCC scores in febrile neutropenic patients monitored in the intensive care unit

Original Article

A cross-sectional examination of caregiver mental health and childhood cancer survivors’ tobacco, alcohol, and marijuana use

Original Article

Impact of care pathway for nursing home residents treated for cancer: ONCO-EHPAD study

Original Article

Is neuroticism relevant for old cancer survivors? A controlled, population-based study (the Norwegian HUNT-3 survey)

Original Article

Nutritional challenges of gastric cancer patients from the perspectives of patients, family caregivers, and health professionals: a qualitative study

Original Article

Screening supportive care needs, compliance with exercise program, quality of life, and anxiety level during the COVID-19 pandemic in individuals treated with hematopoietic stem cell transplantation
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits